文献速递眼底病与葡萄膜炎

玻璃体内注射头孢他啶短期治疗梅毒性葡萄膜炎

Short-Term Treatment of Syphilitic Uveitis With Intravitreal Ceftazidime.
PubMed 文献 · Am J Ophthalmol · 2025-03-26

这项回顾性介入病例系列纳入2019年1月2日至2024年7月1日在一家三级转诊私立诊所诊治的45例梅毒性后葡萄膜炎或全葡萄膜炎患者,其中10例(14眼)在启动青霉素治疗前接受玻璃体内注射头孢他啶(2.25 mg/0.1 mL)短期治疗;14眼炎症指标均改善,9眼可测Snellen视力平均提高5.4行(范围+1至+9);作者认为头孢他啶或可用于此类患者的诊疗。

要点

  • 10例(14眼)在青霉素治疗前接受玻璃体内注射头孢他啶(2.25 mg/0.1 mL),14眼炎症指标均改善。
  • 9眼基线可测Snellen视力,治疗后全部提高,平均提高5.4行(范围+1至+9)。
  • 2眼房水细菌PCR初始梅毒螺旋体阳性,青霉素启动前复查转阴。

核心结论

  • 患者在接受青霉素治疗前使用玻璃体内注射头孢他啶后,视力和炎症均改善,提示头孢他啶或可用于梅毒性葡萄膜炎患者的诊疗。
  • 近十年来全国梅毒病例数增加,加之青霉素短缺日益严重,考虑辅助治疗以改善梅毒性葡萄膜炎的视力结局至关重要。

研究设计与样本

  • 回顾性介入病例系列。
  • 2019年1月2日至2024年7月1日在一家三级转诊私立诊所诊治的45例梅毒性后葡萄膜炎或全葡萄膜炎患者中,10例(14眼)在启动青霉素治疗前接受玻璃体内注射头孢他啶短期治疗。
  • 其中3例以病例形式呈现,以突出可能导致治疗延迟的因素。
  • 干预为1次或多次玻璃体内注射头孢他啶2.25 mg/0.1 mL。

主要发现

  • 接受玻璃体内注射头孢他啶后、青霉素治疗前,全部14眼炎症参数均改善。
  • 9眼基线可测Snellen视力,全部提高,平均提高5.4行(范围+1至+9)。
  • 2眼房水细菌PCR初始梅毒螺旋体阳性,在启动青霉素前复查PCR转阴。
  • 所有患者最终均接受确定性全身抗生素治疗,梅毒性葡萄膜炎均消退。

临床怎么用

  • 作者认为,玻璃体内注射头孢他啶或可用于梅毒性葡萄膜炎患者的诊疗。
  • 作者指出,鉴于梅毒病例增加与青霉素短缺,考虑辅助治疗以改善梅毒性葡萄膜炎视力结局至关重要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To review the clinical outcomes of patients with ocular syphilis that were treated in the short-term with intravitreal ceftazidime when definitive treatment with penicillin was delayed due to a variety of extenuating circumstances. DESIGN: Retrospective interventional case series. PARTICIPANTS: A total of 45 patients diagnosed and treated for syphilitic posterior or panuveitis between January 2, 2019, and July 1, 2024, at a tertiary referral private practice. Of these, 10 patients (n = 14 eyes) were treated short-term with intravitreal ceftazidime before initiating penicillin therapy. Three of these patients are presented as cases to highlight factors that might contribute to treatment delays. INTERVENTION: One or more intravitreal injections of 2.25 mg/0.1 mL ceftazidime. MAIN OUTCOME MEASURES: Visual acuity, inflammatory grade based on Standardization for Uveitis Nomenclature criteria, causes for delay in systemic antibiotic treatment, changes in aqueous bacterial polymerase chain reaction (PCR) following ceftazidime administration, changes in multimodal imaging. RESULTS: Following treatment with intravitreal ceftazidime and prior to penicillin treatment, all eyes (n = 14) had improved inflammatory parameters. Of the 9 eyes with measurable baseline Snellen vision, all improved by an average of 5.4 lines (range = +1 to 9). In the two eyes of patients for whom aqueous bacterial PCR was initially positive for Treponema pallidum, subsequent PCR was negative prior to initiation of penicillin. All patients eventually received definitive systemic antibiotic therapy and had resolution of their syphilitic uveitis. CONCLUSION: Patients experienced improvements in visual acuity and inflammation when treated with intravitreal ceftazidime before the initiation of penicillin, suggesting that ceftazidime could be leveraged in care for those with syphilitic uveitis. With the increasing number of cases of syphilis nationally over the last decade, combined with the growing shortages of penicillin, it is vital to consider adjunctive therapies for treatment of syphilitic uveitis to help improve visual outcomes.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Davis EC, Thomas AS. Short-Term Treatment of Syphilitic Uveitis With Intravitreal Ceftazidime. Am J Ophthalmol. 2025. PMID: 40154908. doi:10.1016/j.ajo.2025.03.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。